<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Our Dermatol Online</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-9-73</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20181.21</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pilomatricoma of the eyelid</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Arif</surname>
<given-names>Tasleem</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amin</surname>
<given-names>Syed Suhail</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Raj</surname>
<given-names>Dinesh</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
</contrib-group>
<aff id="aff1"><italic>Department of Dermatology, STDs and Leprosy, Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), Aligarh, India</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Tasleem Arif, E-mail: <email xlink:href="dr_tasleem_arif@yahoo.com">dr_tasleem_arif@yahoo.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>9</volume>
<issue>1</issue>
<fpage>73</fpage>
<lpage>74</lpage>
<history>
<date date-type="received"><day>28</day><month>05</month><year>2017</year></date>
<date date-type="accepted"><day>20</day><month>08</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 1</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>Pilomatricoma is an uncommon benign tumor considered to be harmatoma of hair matrix. Here we present a case of 27 year old male patient who had solitary swelling over the right upper eyelid. On the basis of clinical and histopathological background, the diagnosis of pilomatricoma was made.</p>
</abstract>
<kwd-group>
<kwd>Hair matrix</kwd>
<kwd>Hamartoma</kwd>
<kwd>Pilomatricoma</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Pilomatricoma was first described by Albert Hippolyte Malherbe and J. Chenantais as calcifying epithelioma in 1880 A.D [<xref ref-type="bibr" rid="ref1">1</xref>]. Later on, in 1949 Lever and Griesemer suggested the hair matrix cells to be the origin of the tumor and finally in 1961 Forbis and Helwig proposed the currently accepted name &#x201C;pilomatricoma&#x201D; [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>].</p>
<p>Clinically, the lesion appears as a slowly enlarging, irregularly shaped, rock hard, nodular, non tender mass freely movable over the subcutaneous tissue. The skin usually has reddish to blue discoloration due to dilated blood vessels and chalky white nodules may be seen through the skin. There is typically no history of inflammation or trauma [<xref ref-type="bibr" rid="ref4">4</xref>]. In this article we present a case of pilomatricoma involving the eyelid.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>CASE REPORT</title>
<p>A 27 years old male presented to the hospital with a small painless nodular lesion in the right upper eyelid for 5 years. The history of the patient revealed no pain, previous inflammation or trauma. On examination, a small, round, non-tender, rock hard, nodule was present on right upper eyelid (Figs. <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>). There was hair shaft emanating from the summit of the nodule. It had normal skin color, but chalky white nodules could be seen through the healthy appearing skin. The patient was referred to ophthalmology department where the lesion was excised and sent for histopathological examination which confirmed the diagnosis of pilomatricoma showing a biphasic population composed of basaloid germinative cells and eosinophil shadow cells with a few foci of dystrophic calcification.</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>A single nodule present over the upper eyelid margin with hair shaft emanating from the centre of the nodule.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-9-73-g001.tif"/>
</fig>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Closer view of the pilomatricoma of the upper eyelid showing hair shaft emerging from the summit of the nodule.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-9-73-g002.tif"/>
</fig>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Pilomatricoma is an ectodermic tumour originating from pluripotential precursors of hair matrix cells. It can present at any age. It demonstrates a bimodal peak presentation during 1<sup>st</sup> and 6<sup>th</sup> decades of life, about 40&#x0025; of cases occur in patients younger than 10 years of age and 60&#x0025; of cases occur within the first two decades of life. Its more common in females than in males [<xref ref-type="bibr" rid="ref5">5</xref>]. Clinically, it manifests as asymptomatic, benign solitary, soft and friable to hard nodule measuring 0.5 cm to 5.0 cm. It is subcutaneous slow growing tumor which may or may not be attached to the skin and mobile over underlying structures. It may also present as multiple and nodular pattern in 2&#x0025; - 10&#x0025; of the cases. An activation of &#x03B2; catenin gene CTNNBI mutation may be the cause for development of familial pilomatricoma [<xref ref-type="bibr" rid="ref6">6</xref>]. Multiple and familial pilomatricomas are associated with Steinert&#x2019;s myotonic dystrophy, Gardner Syndrome, Turner Syndrome and Trisomy 9 [<xref ref-type="bibr" rid="ref7">7</xref>]. Among lesions that need to be differentiated from a pilomatricoma include epidermal inclusion cyst, sebaceous adenoma, dermoid cyst, epidermoid cyst and vascular tumors.</p>
<p>Histologically, pilomatricoma is characterized by a mass made up by basaloid cells in periphery, ghost cells in central part and calcification and sometimes ossification. The ghost cells represent necrotic areas of previously vital basaloid cells. The calcification and ossification areas appear progressively in necrotic areas. Ghost cells are pathognomic of pilomatricoma[<xref ref-type="bibr" rid="ref8">8</xref>].</p>
<p>Presenting age of 27 years, eyelid affliction, male sex and absence of any predisposing factors like trauma make our case an uncommon presentation of pilomatricoma and hence reported.</p>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malherbe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chenantais</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Note Sur L&#x0027;epitheliome calcifie des glades sebacees</article-title>
<source>Programme Med</source>
<year>1888</year>
<volume>8</volume>
<fpage>826</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lever</surname>
<given-names>WF</given-names>
</name>
<name>
<surname>Griesemer</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Calcifying epithelioma of Malherbe;report of 15 cases, with comments on its differentiation from calcified epidermal cyst and on its histogenesis</article-title>
<source>Arch Derm Syphilol</source>
<year>1949</year>
<volume>59</volume>
<fpage>506</fpage>
<lpage>18</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forbis</surname>
<given-names>R</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Helwig</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>Pilomatrixoma (calcifyng epithelioma)</article-title>
<source>Arch Dermatol</source>
<year>1961</year>
<volume>83</volume>
<fpage>606</fpage>
<lpage>18</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abalo-Lojo</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cameselle-Teijeiro</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Pilomatrixoma:late onset in two periocular cases</article-title>
<source>Ophthal Plast Reconstr Surg</source>
<year>2008</year>
<volume>24</volume>
<fpage>60</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taaffe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wyatt</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Bury</surname>
<given-names>HP</given-names>
</name>
</person-group>
<article-title>Pilomatrixoma (Malherbe):A clinical and histo pathologic survey of 78 cases</article-title>
<source>Int J Dermatol</source>
<year>1988</year>
<volume>27</volume>
<fpage>477</fpage>
<lpage>80</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>E.F</given-names>
</name>
<name>
<surname>Gat</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Mc Niff</surname>
<given-names>J.M</given-names>
</name>
<name>
<surname>Fuchus</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>A Common Human Skin Tumor Is Caused by Activating Mutation of &#946;-Catenin</article-title>
<source>Nature Genetics</source>
<year>1999</year>
<volume>21</volume>
<fpage>410</fpage>
<lpage>13</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aslan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Erdogan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Akoz</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gorgu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seckin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Terzioglu</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Multiple occurrence of pilomatrixoma</article-title>
<source>Plast Reconstr Surg Sept</source>
<year>1996</year>
<volume>98</volume>
<fpage>510</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Passi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chawla</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Jyoti Khurana</surname>
<given-names>AK</given-names>
</name>
</person-group>
<article-title>Pilomatrixoma of eyelid in a middle aged</article-title>
<source>Nepal J Ophthalmol</source>
<year>2011</year>
<volume>3</volume>
<fpage>88</fpage>
<lpage>90</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>